Literature DB >> 1802557

Drug removal during continuous hemofiltration or hemodialysis.

T A Golper1.   

Abstract

Mesh：

Substances：

Year:  1991        PMID： 1802557     DOI： 10.1159/000420197

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN： 0302-5144            Impact factor:   1.580


× No keyword cloud information.
  12 in total

Review 1.  Pharmacokinetics of continuous renal replacement therapy.

Authors:  M Schetz; P Ferdinande; G Van den Berghe; C Verwaest; P Lauwers
Journal:  Intensive Care Med       Date:  1995-07       Impact factor: 17.440

Review 2.  Antibiotic dosing in critically ill patients with acute kidney injury.

Authors:  Rachel F Eyler; Bruce A Mueller
Journal:  Nat Rev Nephrol       Date:  2011-02-22       Impact factor: 28.314

Review 3.  Drug dosage in patients during continuous renal replacement therapy. Pharmacokinetic and therapeutic considerations.

Authors:  P Reetze-Bonorden; J Böhler; E Keller
Journal:  Clin Pharmacokinet       Date:  1993-05       Impact factor: 6.447

4.  Single-dose pharmacokinetics of meropenem during continuous venovenous hemofiltration.

Authors:  F Thalhammer; P Schenk; H Burgmann; I El Menyawi; U M Hollenstein; A R Rosenkranz; G Sunder-Plassmann; S Breyer; K Ratheiser
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

5.  Cortisol and catecholamine kinetics during continuous hemodiafiltration in patients with multiple organ dysfunction syndrome.

Authors:  T Tsubo; Y Hashimoto; I Araki; H Ishihara; A Matsuki
Journal:  Intensive Care Med       Date:  1996-11       Impact factor: 17.440

6.  Pharmacokinetics and pharmacodynamics of imipenem during continuous renal replacement therapy in critically ill patients.

Authors:  Douglas N Fish; Isaac Teitelbaum; Edward Abraham
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

7.  Pharmacokinetics of cefepime during continuous renal replacement therapy in critically ill patients.

Authors:  R S Malone; D N Fish; E Abraham; I Teitelbaum
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

Review 8.  Drug dosing during intermittent hemodialysis and continuous renal replacement therapy : special considerations in pediatric patients.

Authors:  Michael A Veltri; Alicia M Neu; Barbara A Fivush; Rulan S Parekh; Susan L Furth
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

Review 9.  Clinical pharmacokinetics during continuous haemofiltration.

Authors:  F Bressolle; J M Kinowski; J E de la Coussaye; N Wynn; J J Eledjam; M Galtier
Journal:  Clin Pharmacokinet       Date:  1994-06       Impact factor: 6.447

Review 10.  A review of continuous renal replacement therapy.

Authors:  C G Flynn
Journal:  Ir J Med Sci       Date:  1994-07       Impact factor: 1.568
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.